Zobrazeno 1 - 10
of 12
pro vyhledávání: '"David Bibi"'
Publikováno v:
Pharmaceutics, Vol 16, Iss 7, p 896 (2024)
The interest in the development and therapeutic application of long-acting injectable products for chronic or long-term treatments has experienced exponential growth in recent decades. TV-46000 (Uzedy, Teva) is a long-acting subcutaneous (sc) injecta
Externí odkaz:
https://doaj.org/article/e6298492b68d4b7592574b3b7f693b17
Autor:
Nina Nauwelaerts, Julia Macente, Neel Deferm, Rodolfo Hernandes Bonan, Miao-Chan Huang, Martje Van Neste, David Bibi, Justine Badee, Frederico S. Martins, Anne Smits, Karel Allegaert, Thomas Bouillon, Pieter Annaert
Publikováno v:
Pharmaceutics, Vol 15, Iss 5, p 1469 (2023)
Women commonly take medication during lactation. Currently, there is little information about the exposure-related safety of maternal medicines for breastfed infants. The aim was to explore the performance of a generic physiologically-based pharmacok
Externí odkaz:
https://doaj.org/article/11f1b5bd790e446a9b2a3b6512657899
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 34, Iss 1, Pp 1078-1082 (2019)
3-Methylpentyl(4-sulphamoylphenyl)carbamate (MSPC) came as the most potent compound out of a new series of carbamates composed of phenyl-ethanol or branched aliphatic alcohols, and 4-benzenesulphonamide-carbamic acid. In this study, the anticonvulsan
Externí odkaz:
https://doaj.org/article/92bcde199f7a4c4d8bddc75382e327ec
Publikováno v:
Epilepsia. 61:1543-1552
The success rate from first time in man to regulatory approval of central nervous system (CNS) drugs is lower than the overall success rate across all therapeutic indications (eg, cardiovascular, infectious diseases). To understand the reasons for dr
Autor:
Liana M. Matson, Robyn B. Lee-Stubbs, Kari M. Haines, David Bibi, Cherish E. Ardinger, John H. McDonough, Emily N. Dunn, Meir Bialer
Publikováno v:
Epilepsia. 60:315-321
Objectives Children and adults are likely to be among the casualties in a civilian nerve agent exposure. This study evaluated the efficacy of valnoctamide (racemic-VCD), sec-butylpropylacetamide (racemic-SPD), and phenobarbital for stopping nerve age
Autor:
Bella Shusterman, Claudiu T. Supuran, Natalia Erenburg, Reem Odi, David Bibi, Chanan Shaul, Meir Bialer, Alessio Nocentini
Publikováno v:
International Journal of Molecular Sciences
Volume 22
Issue 7
International Journal of Molecular Sciences, Vol 22, Iss 3361, p 3361 (2021)
Volume 22
Issue 7
International Journal of Molecular Sciences, Vol 22, Iss 3361, p 3361 (2021)
We recently reported a new class of carbamate derivatives as anticonvulsants. Among these, 3-methylpentyl(4-sulfamoylphenyl)carbamate (MSPC) stood out as the most potent compound with ED50 values of 13 mg/kg (i.p.) and 28 mg/kg (p.o.) in the rat maxi
Autor:
David Bibi, Hafiz Mawasi, Bogdan J. Wlodarczyk, Meir Bialer, Alessio Nocentini, Claudiu T. Supuran, Richard H. Finnell
Publikováno v:
Neurochemical Research. 42:1972-1982
Epilepsy is one of the most common neurological diseases, with between 34 and 76 per 100,000 people developing epilepsy annually. Epilepsy therapy for the past 100+ years is based on the use of antiepileptic drugs (AEDs). Despite the availability of
Autor:
David Bibi, Meir Bialer
Publikováno v:
EpilepsiaREFERENCES. 61(1)
OBJECTIVES To advance the development of (2S,3S)-sec-butylpropylacetamide (SPD) as a new treatment for acute repetitive seizures (ARS), by studying its pharmacokinetics (PK) in pigs and its PK-pharmacodynamic (PK-PD) correlation in rats. METHODS Two
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 34, Iss 1, Pp 1078-1082 (2019)
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 34, Iss 1, Pp 1078-1082 (2019)
3-Methylpentyl(4-sulphamoylphenyl)carbamate (MSPC) came as the most potent compound out of a new series of carbamates composed of phenyl-ethanol or branched aliphatic alcohols, and 4-benzenesulphonamide-carbamic acid. In this study, the anticonvulsan
Publikováno v:
Molecular Pharmaceutics. 13:2492-2496
sec-Butylpropylacetamide (SPD) is the amide derivative of valproic acid (VPA). SPD possess a wide-spectrum anticonvulsant profile better than that of VPA and blocks status epilepticus (SE) induced by pilocarpine and organophosphates. The activity of